In this Section |
199610 Treatment patterns for incident depression episode among women veterans with or at risk for cardiovascular conditionsTuesday, November 10, 2009: 1:30 PM
BACKGROUND: Treatment of depression among individuals with heart disease or diabetes is important because of its beneficial effects in reducing mortality, recurrence of heart disease, and healthcare expenditures. Post-hoc analysis of the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study found an association between reduction in death rates or recurrent MI and antidepressant use.
OBJECTIVE: Examine treatment patterns for incident depression episode among veteran women with or at risk for cardiovascular conditions. METHODS: Longitudinal data (2002-2003) of merged Veteran Health Administration (VHA) and Medicare data on women veterans with diabetes or heart disease or hypertension (N = 54,166); these conditions and depression were identified using International Classification of Codes, 9th edition, clinical modification codes. Chi-square tests and multinomial logistic regressions were performed to analyze depression treatment patterns. FINDINGS: Overall, 15% (N = 8,147) of veteran women with Cardiovascular Conditions were diagnosed with a new episode of depression in fiscal year 2003. Of these women 77% received treatment for depression–54% only antidepressants; 4% only psychotherapy; 19% both. After controlling for demographic, socio-economic, and other physical and mental health conditions, African Americans, older women, those with heart disease and serious mental illness were less likely to receive any treatment for depression. CONCLUSION: Although overall rates of treatment for depression were high among veteran women with chronic physical illnesses, many subgroups of women veterans were vulnerable to not receiving treatment for depression. IMPLICATION: Further research and targeted interventions are needed to promote treatment for depression and eliminate disparities in treatment for depression.
Learning Objectives:
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I am the first author of the paper. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: Health Care for Women Veterans: Caring for Those who Serve Our Country
See more of: Women's Caucus |